ProPhase Labs leads stock surge with 506% gain after reverse stock split announcement.

ProPhase Labs' stock soared 506.62% to $27.48 following a 1-for-4 reverse stock split aimed at consolidating shares and boosting price per share. Other notable gainers include Inpixon (+113%), Super League Gaming (+82%) after a major Bitcoin investment, Amylyx Pharmaceuticals (+64%) with a $350M public offering, and China SXT Pharmaceuticals (+37%) after share consolidation. These gains reflect strategic corporate actions like stock consolidations, capital raising, and major investments reshaping company valuations and attracting investor interest.